Order Article Reprints

Steendam CMJ, Veerman GDM, Pruis MA, Atmodimedjo P, Paats MS, van der Leest C, von der Thüsen JH, Yick DCY, Oomen-de Hoop E, Koolen SLW, et al. Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer. Cancers. 2020; 12(11):3179. https://doi.org/10.3390/cancers12113179

Steendam, Christi M. J., G. D. Marijn Veerman, Melinda A. Pruis, Peggy Atmodimedjo, Marthe S. Paats, Cor van der Leest, Jan H. von der Thüsen, David C. Y. Yick, Esther Oomen-de Hoop, Stijn L. W. Koolen, and et al. 2020. "Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer" Cancers 12, no. 11: 3179. https://doi.org/10.3390/cancers12113179

Steendam, C. M. J., Veerman, G. D. M., Pruis, M. A., Atmodimedjo, P., Paats, M. S., van der Leest, C., von der Thüsen, J. H., Yick, D. C. Y., Oomen-de Hoop, E., Koolen, S. L. W., Dinjens, W. N. M., van Schaik, R. H. N., Mathijssen, R. H. J., Aerts, J. G. J. V., Dubbink, H. J., & Dingemans, A.-M. C. (2020). Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer. Cancers, 12(11), 3179. https://doi.org/10.3390/cancers12113179